Chromatographic detection using tris(2,2'-bipyridyl)ruthenium(III) as a fluorogenic electron-transfer reagentWOLTMAN, S. J; EVEN, W. R; WEBER, S. G et al.Analytical chemistry (Washington, DC). 1999, Vol 71, Num 8, pp 1504-1512, issn 0003-2700Article

Matrix-assisted laser desorption mass spectrometry of biotransformation products of dynorphin A in vitroCHOU, J. Z; KREEK, M. J; CHAIT, B. T et al.Journal of the American Society for Mass Spectrometry. 1994, Vol 5, Num 1, pp 10-16, issn 1044-0305Article

Acute subjective effects of dynorphin A(1-13) infusion in normal healthy subjectsKING, A. C; HO, A; SCHLUGER, J et al.Drug and alcohol dependence. 1999, Vol 54, Num 1, pp 87-90, issn 0376-8716Article

Nouvelles méthodes de synthèse des endothiopeptides = Research of new methods for the synthesis of endothiopeptidesLe, Hoang Thanh; Michelot, R.1996, 173 p.Thesis

CSF opioids in panic disorderBRADY, K. T; LYDIARD, R. B; BALLENGER, J. C et al.Biological psychiatry (1969). 1991, Vol 30, Num 5, pp 512-514, issn 0006-3223Article

Assessment of complex peptide degradation pathways via structured multicompartmental modeling approaches : The metabolism of dynorphin A1-13 and related fragments in human plasmaMÜLLER, S; HUTSON, A; ARYA, V et al.Journal of pharmaceutical sciences. 1999, Vol 88, Num 9, pp 938-944, issn 0022-3549Article

Prediction of the conformational requirements for binding to the κ-opioid receptor and its subtypes. I: Novel α-helical cyclic peptides and their role in receptor selectivityCOLLINS, N; HRUBY, V. J.Biopolymers. 1994, Vol 34, Num 9, pp 1231-1241, issn 0006-3525Article

Dynorphin-A and vasopressin release in the rat : a structure-activity studyVAN DE HEIJNING, B. J. M; MAIGRET, C; KOEKKOEK-VAN DEN HERIK, I et al.Neuropeptides (Edinburgh). 1994, Vol 26, Num 6, pp 371-378, issn 0143-4179Article

Characterization of non-opioid [³H]dynorphin A-(1-13) binding sites in the rat heartDUMONT, M; LEMAIRE, S.Journal of molecular and cellular cardiology. 1993, Vol 25, Num 8, pp 983-991, issn 0022-2828Article

Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanismFADEN, A. I.The Journal of neuroscience. 1992, Vol 12, Num 2, pp 425-429, issn 0270-6474Article

Possible regulatory role of dynorphin A in the urinary bladderBERGGREN, A; DAHLSTRÖM, A; RUBENSON, A et al.Journal of neural transmission. 1992, Vol 90, Num 1, pp 33-44, issn 0300-9564Article

Reduced cerebrospinal fluid dynorphin A_1-8 in Alzheimer's diseaseSUNDERLAND, T; BERRETTINI, W. H; MOLCHAN, S. E et al.Biological psychiatry (1969). 1991, Vol 30, Num 1, pp 81-87, issn 0006-3223Article

Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions 1,6,7,8 and 10KAWASAKI, A. M; KNAPP, R. J; WALTON, A et al.International journal of peptide & protein research. 1993, Vol 42, Num 5, pp 411-419, issn 0367-8377Article

Demonstration of dynorphin A 1-8 immunoreactive axons contacting spinal cord projection neurons in a rat model of peripheral inflammation and hyperalgesiaNAHIN, R. L; HYLDEN, J. L. K; HUMPHREY, E et al.Pain (Amsterdam). 1992, Vol 51, Num 2, pp 135-143, issn 0304-3959Article

Dynorphin blocks opioid inhibition of macrophage-colony stimulating factor-induced proliferation of bone marrow cellsROY, S; LOH, H. H; LEE, N. M et al.European journal of pharmacology. 1991, Vol 202, Num 3, pp 355-359, issn 0014-2999Article

Hippocampal levels of dynorphin A (1-8) in neonatal and 16-week-old spontaneously hypertensive rats : comparisons with DOCA-salt hypertensionLI, S.-J; HONG, J. S; INGENITO, A. J et al.Neurochemical research. 1990, Vol 15, Num 11, pp 1141-1146, issn 0364-3190, 6 p.Article

Prodynorphin peptide distribution in the forebrain of the Syrian hamster and rat: a comparative study with antisera against dynorphin A, dynophin B, and the C-terminus of the prodynorphin precursor moleculeNEAL, C. R; NEWMAN, S. W.Journal of comparative neurology (1911). 1989, Vol 288, Num 3, pp 353-386, issn 0021-9967, 34 p.Article

Design of potent dynorphin A-(1-9) analogues devoid of supraspinal motor effects in miceLE, H.-T; MICHELOT, R; DUMONT, M et al.Canadian journal of physiology and pharmacology. 1997, Vol 75, Num 1, pp 9-14, issn 0008-4212Article

Chronic administration of morphine decreases level of dynorphin A in the rat nucleus accumbensYUKHANANOV, R. YU; ZHAI, Q. Z; PERSSON, S et al.Neuropharmacology. 1993, Vol 32, Num 7, pp 703-709, issn 0028-3908Article

Mimicking the membrane-mediated conformation of dynorphin A-(1-13)-peptide : circular dichroism and nuclear magnetic resonance studies in methanolic solutionLANCASTER, C. R. D; MISHRA, P. K; HUGHES, D. W et al.Biochemistry (Easton). 1991, Vol 30, Num 19, pp 4715-4726, issn 0006-2960, 12 p.Article

Des-tyrosine dynorphin A-(2-13) improves carbon monoxide-induced impairment of learning and memory in miceHIRAMATSU, M; INOUE, K.Brain research. 2000, Vol 859, Num 2, pp 303-310, issn 0006-8993Article

Effects of the k-opioid dynorphin A(1-13) on learning and memory in miceUKAI, M; ITOH, J; KOBAYASHI, T et al.Behavioural brain research. 1997, Vol 83, Num 1-2, pp 169-172, issn 0166-4328Conference Paper

Distribution of dynorphin A (1-17) in the cat brainstem: an immunocytochemical studyMARCOS, P; COVENAS, R; NARVAEZ, J. A et al.Archives italiennes de biologie (1957). 1994, Vol 132, Num 2, pp 73-84, issn 0003-9829Article

Cardiovascular responses to intra-hippocampal dynorphin A-(1-8) in spontaneously hypertensive ratsWANG, J. Q; INGENITO, A. J.European journal of pharmacology. 1994, Vol 256, Num 1, pp 57-64, issn 0014-2999Article

Interaction of I.V. dynorphin A(1-13) with kappa and mu agonists in a thermal antinociception assay in rhesus monkeysBUTELMAN, E. R; FRANCE, C. P; WOODS, J. H et al.Regulatory peptides. 1994, pp S87-S88, issn 0167-0115, SUP1Conference Paper